EncompaaS has launched a groundbreaking Contract Validation and Analytics (CVA) tool specifically for pharmaceutical manufacturers. This AI-powered solution automates the extraction and analysis of formulary data against contractual terms, helping identify missed revenue opportunities. Originally developed for a major global pharmaceutical player, the CVA tool allows manufacturers to swiftly detect discrepancies between contracts and formularies, previously a time-consuming process. “With our CVA tool, companies can spot misalignments in near real-time, identifying drugs incorrectly listed or not listed at all,” notes David Gould, CCO of EncompaaS.
Key features of the EncompaaS CVA tool include the ability to analyze thousands of formularies automatically, visualize data in a user-friendly dashboard, and export findings for further reporting. By pinpointing inconsistencies that could lead to lost revenue or compliance issues, pharmaceutical manufacturers can strategically improve drug pricing and placement. Enhance revenue potential with the innovative EncompaaS CVA tool today!
Source link
